Evofem Biosciences Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. FDX
2. CBRS
3. USO
4. KBH
5. HTZ
6. SPY
7. HON
8. TTWO
9. MRK
10. SPCX

Go back to Evofem Biosciences Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update

Evofem Biosciences (EVFM) Misses Q4 EPS by 14c

March 4, 2021 4:01 PM EST

Evofem Biosciences (NASDAQ: EVFM) reported Q4 EPS of ($0.50), $0.14 worse than the analyst estimate of ($0.36).

"2020 was a year of execution for Evofem, marked by the approval and U.S. commercial launch of Phexxi, our non-hormonal, on-demand birth control method," said Saundra Pelletier, Chief Executive... More